*ST交昂(600530.SH):上海仁杏擬出售三香老年公寓100%股權
格隆匯5月14日丨*ST交昂(600530.SH)公佈,公司下屬全資子公司上海仁杏健康管理有限公司(以下簡稱“上海仁杏”)擬通過與上海大樹佰愛養老服務有限公司(以下簡稱“大樹佰愛”)簽訂《股權轉讓協議》,轉讓其所持有的蘇州仁杏三香老年公寓有限公司(以下簡稱“三香老年公寓”)100%股權,本次交易股權轉讓價格為人民幣500萬元。
預計此次出售資產對公司2021年度產生淨收益約為366萬元(具體金額和會計處理以審計結果為準),截止2021年4月30日,三香老年公寓應付上市公司及其子公司3581萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.